Cargando…

What can we learn about joint degeneration from rare and orphan diseases?

Detalles Bibliográficos
Autor principal:	Gallagher, JA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674847/ http://dx.doi.org/10.1186/1471-2474-16-S1-S17

Ejemplares similares

Classification and coding of rare diseases: overview of where we stand, rationale, why it matters and what it can change
por: Robinson, Peter N
Publicado: (2012)

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
por: Ries, Markus, et al.
Publicado: (2015)

10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Publicado: (2020)

Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022
Publicado: (2023)

8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016
por: Schlander, Michael, et al.
Publicado: (2016)

Musculoskeletal health from the “One Medicine” perspective – what can we learn from large and small animal models (with emphasis on articular cartilage)?
por: van Weeren, P René, et al.
Publicado: (2015)

Mechanism of coordinated access to orphan drugs
por: DeRidder, R, et al.
Publicado: (2012)

9th European Conference on Rare Diseases & Orphan Products (ECRD Vienna 2018): Vienna, Austria. 10-12 May 2018
Publicado: (2018)

THE PHYSICAL AND MENTAL HEALTH OF HOME HEALTHCARE WORKERS: WHAT DO WE KNOW AND WHAT CAN WE DO ABOUT IT?
por: Sterling, Madeline
Publicado: (2022)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

Multiorgan failure in malaria: what we have learned over the past 10 years
por: Zeippen, B, et al.
Publicado: (2001)

What we learned from bench to bedside with the neuroblastoma targeting CD171-specific CAR
por: Künkele, A, et al.
Publicado: (2015)

Apples and oranges in HEMS – Do we know what we compare?
por: Rasmussen, Kristen, et al.
Publicado: (2015)

Key performance indicators - a tool to answer the questions, what do we get for our money? and how can we use this money even more efficiently?
por: Hansen, M Bork
Publicado: (2010)

Leveraging existing opportunities for improved Orphan Drug approval in the EU
por: Edfjäll, Catarina
Publicado: (2012)

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

Is fever good? What do we actually know?
por: Rhodes, Jonathan KJ
Publicado: (2015)

Listening to children’s and parents’ voices: using patient reported outcomes to empower patients with orphan diseases and their parents
por: Abetz-Webb, Linda
Publicado: (2012)

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

What Psychological Theories of Behavior Change Can Teach Us about Improving Hand Hygiene Adherence: Do We Mean What We Say?
por: Corace, Kimberly, et al.
Publicado: (2017)

Coordinated orphan disease research: yes, we can!
por: Vanakker, Olivier M.
Publicado: (2013)

What can we learn about perpetrators of domestic and familial homicide and their involvement with mental health services from domestic homicide reviews?
por: Macinnes, P.
Publicado: (2021)

Haematological malignancy on the ICU - can we identify survivors?
por: Shah, S, et al.
Publicado: (2001)

MicroRNAs and cancer: what we know and what we still have to learn
por: Calin, George A
Publicado: (2009)

What can we learn about emotion by studying psychopathy?
por: Marsh, Abigail A.
Publicado: (2013)

EHMTI-0248. Evaluation of headache prevalence and characteristics in orphans aged 12-17
por: Senturk, A Ates, et al.
Publicado: (2014)

Pearls collections: What we can learn about infectious disease and cancer
por: Knoll, Laura J., et al.
Publicado: (2018)

Early discharge of term neonates: we can do it safely
por: Luciano, R
Publicado: (2015)

What can we learn about the Higgs with 10/fb at the LHC?
por: Assamagan, K A
Publicado: (2009)

What can we learn about reshoring after Covid-19?
por: Barbieri, Paolo, et al.
Publicado: (2020)

Representing Dutch Older Adults During COVID-19: What Can We Learn?
por: Lindenberg, Jolanda, et al.
Publicado: (2021)

Can we send patients with small pneumothorax post drain removal home?
por: Singh, Sanjeet SA, et al.
Publicado: (2015)

Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2011)

Cervical cancer in Malaysia: can we improve our screening and preventive practice?
por: Varatharajan, Shanthi, et al.
Publicado: (2012)

Transfusional practices: what have we learnt with Transfusion Requirements In Critical Care (TRICC)
por: Mendes, CL, et al.
Publicado: (2003)

What Are We Worried About? Mid-life Couples’ Financial Concerns About Their Retirement
por: Yorgason, Jeremy, et al.
Publicado: (2021)

What we know about Auditory Charles Bonnet Syndrome?
por: Moreno Menguiano, C., et al.
Publicado: (2022)

Suicide among physicians: what do we know about it?
por: Vaz, R. P., et al.
Publicado: (2023)

What do we know about lithium associated hypercalcemia?
por: Laherrán Cantera, N., et al.
Publicado: (2023)

What can we say about the impact of teleconsultations on preventing psychiatric inpatient treatment during COVID-19 pandemic?
por: Figueiredo, I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qjcbvorc72aloutpg8udv05b52